A Gradual Process for Integrating E-learning in a Higher Education Institute

In: A.J. Kallenberg and M.J.J.M. van de Ven (Eds), 2002, The New Educational Benefits of ICT in Higher Education: Proceedings. Rotterdam: Erasmus Plus BV, OECR ISBN 90-9016127-9We describe an incremental process for integrating E-learning in a higher education institute. Our basic assumption is that the burden of integrating E-learning lies mainly on the shoulders of the teachers. We suggest a process based on XML technologies that enables the teachers to: (1) separate content from presentation and concentrate on content (2) develop learning materials incrementally and implement easily at each stage (3) reuse any learning materials they have already prepared (4) reuse learning materials prepared by other teachers. In this paper we describe the process along with the various roles of each of the following: the technology, the support technical team, the individual teacher and the evolving community of practice

Moral parochialism misunderstood: a reply to Piazza and Sousa

Our paper [1] compared two competing hypotheses. The hypothesis that we label universalistic moral evaluation holds that a definitional feature of reasoning about moral rules is that, ceteris paribus, judgements of violations of rules concerning harm, rights or justice will be insensitive to spatial or temporal distance or the opinions of authority figures. The hypothesis that we label moral parochialism, consonant with a variety of theories of the evolutionary origins of morality, holds that, because moral judgements primarily serve to navigate local social arenas, remote events will not activate the mechanisms that generate negative moral evaluation to the same extent as events occurring in the here and now, whereas the consent of local authority figures will temper condemnation. Hence, moral parochialism predicts that the collective output of the faculties responsible for moral judgement will exhibit a reduction in the severity of judgement as a function of spatial or temporal distance or the opinions of local authority figures. We provided evidence from seven diverse societies, including five small-scale societies, showing that such reductions in severity judgements exist in all of the societies examined. Piazza and Sousa [2] argue that our data do not support parochialism, and instead support universalism, because (1) Only a minority of our participants reversed their initial judgement of the wrongness of an action (from wrong to not wrong or good) when it was subsequently framed as having occurred long ago or far away, or as having been sanctioned by authority figures. (2) Our use of graduated moral judgements, rather than dichotomous judgements, is inappropriate. (3) Only a minority of our participants diminished the severity of their initial judgement of the wrongness of an action when it was subsequently framed as having occurred long ago or far away, or as having been sanctioned by an important person. These objections stem from misunderstandings of moral parochialism and the evolutionary reasoning behind it

Small-scale societies exhibit fundamental variation in the role of intentions in moral judgment.

Intent and mitigating circumstances play a central role in moral and legal assessments in large-scale industrialized societies. Although these features of moral assessment are widely assumed to be universal, to date, they have only been studied in a narrow range of societies. We show that there is substantial cross-cultural variation among eight traditional small-scale societies (ranging from hunter-gatherer to pastoralist to horticulturalist) and two Western societies (one urban, one rural) in the extent to which intent and mitigating circumstances influence moral judgments. Although participants in all societies took such factors into account to some degree, they did so to very different extents, varying in both the types of considerations taken into account and the types of violations to which such considerations were applied. The particular patterns of assessment characteristic of large-scale industrialized societies may thus reflect relatively recently culturally evolved norms rather than inherent features of human moral judgment

Short Online Compassionate Intervention Based On Mindful Self-compassion Program

Objectives. The Mindful Self-Compassion (MSC) program is an empirically-developed group intervention aimed to cultivate self-compassion. Sample and setting. A randomized control trial was conducted with pre-, post-measurements, and two-month follow-up. A total of 122 participants were recruited from a general community by convenience sampling. They were randomly allocated to the Compassionate intervention (CI) based on MSC and to a control condition with no treatment. Hypotheses. The authors hypothesised that participation in the CI based on the MSC would decrease self-criticism and increase self-reassurance and self-compassion. Statistical analysis. SPSS Statistics-20, program R, and the package nparLD for the statistical analysis. Non-parametric rank-based test for longitudinal data (pretest-postest design) was employed. Results. This version of the CI based on the MSC significantly increased levels of selfcompassion and self-reassurance as reported immediately post intervention and at two-month follow-up. The CI based on the MSC was also effective at reducing self-uncompassionate responding, which was only present immediately post intervention. Self-compassion is responsive to improvement following a short-term online intervention of CI based on the MSC which suggests that interventions designed to increase self-compassion can be provided online to broader populations without direct involvement of mental health professionals. Study limitation. Participants allocated to the CI were not exposed to the full experience of the MSC but only to a selected number of exercises from the MSC program

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND). a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Background: Although several disease-modifying treatments are available for relapsing multiple sclerosis, treatment effects have been more modest in progressive multiple sclerosis and have been observed particularly in actively relapsing subgroups or those with lesion activity on imaging. We sought to assess whether natalizumab slows disease progression in secondary progressive multiple sclerosis, independent of relapses. Methods: ASCEND was a phase 3, randomised, double-blind, placebo-controlled trial (part 1) with an optional 2 year open-label extension (part 2). Enrolled patients aged 18–58 years were natalizumab-naive and had secondary progressive multiple sclerosis for 2 years or more, disability progression unrelated to relapses in the previous year, and Expanded Disability Status Scale (EDSS) scores of 3·0–6·5. In part 1, patients from 163 sites in 17 countries were randomly assigned (1:1) to receive 300 mg intravenous natalizumab or placebo every 4 weeks for 2 years. Patients were stratified by site and by EDSS score (3·0–5·5 vs 6·0–6·5). Patients completing part 1 could enrol in part 2, in which all patients received natalizumab every 4 weeks until the end of the study. Throughout both parts, patients and staff were masked to the treatment received in part 1. The primary outcome in part 1 was the proportion of patients with sustained disability progression, assessed by one or more of three measures: the EDSS, Timed 25-Foot Walk (T25FW), and 9-Hole Peg Test (9HPT). The primary outcome in part 2 was the incidence of adverse events and serious adverse events. Efficacy and safety analyses were done in the intention-to-treat population. This trial is registered with ClinicalTrials.gov, number NCT01416181. Findings: Between Sept 13, 2011, and July 16, 2015, 889 patients were randomly assigned (n=440 to the natalizumab group, n=449 to the placebo group). In part 1, 195 (44%) of 439 natalizumab-treated patients and 214 (48%) of 448 placebo-treated patients had confirmed disability progression (odds ratio [OR] 0·86; 95% CI 0·66–1·13; p=0·287). No treatment effect was observed on the EDSS (OR 1·06, 95% CI 0·74–1·53; nominal p=0·753) or the T25FW (0·98, 0·74–1·30; nominal p=0·914) components of the primary outcome. However, natalizumab treatment reduced 9HPT progression (OR 0·56, 95% CI 0·40–0·80; nominal p=0·001). In part 1, 100 (22%) placebo-treated and 90 (20%) natalizumab-treated patients had serious adverse events. In part 2, 291 natalizumab-continuing patients and 274 natalizumab-naive patients received natalizumab (median follow-up 160 weeks [range 108–221]). Serious adverse events occurred in 39 (13%) patients continuing natalizumab and in 24 (9%) patients initiating natalizumab. Two deaths occurred in part 1, neither of which was considered related to study treatment. No progressive multifocal leukoencephalopathy occurred. Interpretation: Natalizumab treatment for secondary progressive multiple sclerosis did not reduce progression on the primary multicomponent disability endpoint in part 1, but it did reduce progression on its upper-limb component. Longer-term trials are needed to assess whether treatment of secondary progressive multiple sclerosis might produce benefits on additional disability components. Funding: Biogen

Effect of a Short-Term Online Version of a Mindfulness-Based Intervention on Self-criticism and Self-compassion in a Nonclinical Sample

Our goal was to investigate the efficacy of a Mindfulness-Based Intervention (MBI) in the form of a short-term, online intervention using exercises from Mindfulness-Based Stress-Reduction program on self-compassion, self-reassurance and self-criticism in a non-clinical population. We conducted pre-, post- and two-month follow-up measures of self-compassion, self-reassurance and self-criticism. A total of 146 participants, recruited through convenience sampling, were randomly allocated to the intervention with daily exercises for consecutive 15 days and to a control condition with no treatment. The intervention group reported a significant reduction in self-criticism and self-uncompassionate responding with effects present at two-month follow-up. There was a short-term effect of the training on self-compassion with no effect present at the two-month follow-up and no significant effect on self-reassurance. A limitation of the study is that participants’ previous experience with meditation was not assessed, and thus the findings may be a result of previous meditation practice and not the intervention itself. Despite this limitation, the findings show that an online short-term MBI may be helpful in reducing selfcriticism in general population, but a larger study taking into account the limitations needs to be conducted to replicate this effect before recommendations for clinical practice can be made

Intentional coronary revascularization versus conservative therapy in patients after peripheral artery revascularization due to critical limb ischemia : the INCORPORATE trial

INCORPORATE trial was designed to evaluate whether default coronary-angiography (CA) and ischemia-targeted revascularization is superior compared to a conservative approach for patients with treated critical limb ischemia (CLI). Registered at clinicaltrials.gov (NCT03712644) on October 19, 2018.Severe peripheral artery disease is associated with increased cardiovascular risk and poor outcomes.INCORPORATE was an open-label, prospective 1:1 randomized multicentric trial that recruited patients who had undergone successful CLI treatment. Patients were randomized to either a conservative or invasive approach regarding potential coronary artery disease (CAD). The conservative group received optimal medical therapy alone, while the invasive group had routine CA and fractional flow reserve-guided revascularization. The primary endpoint was myocardial infarction (MI) and 12-month mortality.Due to COVID-19 pandemic burdens, recruitment was halted prematurely. One hundred eighty-five patients were enrolled. Baseline cardiac symptoms were scarce with 92% being asymptomatic. Eighty-nine patients were randomized to the invasive approach of whom 73 underwent CA. Thirty-four percent had functional single-vessel disease, 26% had functional multi-vessel disease, and 90% achieved complete revascularization. Conservative and invasive groups had similar incidences of death and MI at 1 year (11% vs 10%; hazard ratio 1.21 [0.49-2.98]). Major adverse cardiac and cerebrovascular events (MACCE) trended for hazard in the Conservative group (20 vs 10%; hazard ratio 1.94 [0.90-4.19]). In the per-protocol analysis, the primary endpoint remained insignificantly different (11% vs 7%; hazard ratio 2.01 [0.72-5.57]), but the conservative approach had a higher MACCE risk (20% vs 7%; hazard ratio 2.88 [1.24-6.68]).This trial found no significant difference in the primary endpoint but observed a trend of higher MACCE in the conservative arm

Improvements in Compassion and Fears of Compassion throughout the COVID-19 Pandemic: A Multinational Study

During large-scale disasters, social support, caring behaviours, and compassion are shown to protect against poor mental health outcomes. This multi-national study aimed to assess the fluctuations in compassion over time during the COVID-19 pandemic. Respondents (Time 1 n = 4156, Time 2 n = 980, Time 3 n = 825) from 23 countries completed online self-report questionnaires measuring the flows of compassion (i.e., Compassionate Engagement and Action Scales) and fears of compassion toward self and others and from others (i.e., Fears of Compassion Scales) and mental health at three time-points during a 10-month period. The results for the flows of compassion showed that self-compassion increased at Time 3. Compassion for others increased at Time 2 and 3 for the general population, but in contrast, it decreased in health professionals, possibly linked to burnout. Compassion from others did not change in Time 2, but it did increase significantly in Time 3. For fears of compassion, fears of self-compassion reduced over time, fears of compassion for others showed more variation, reducing for the general public but increasing for health professionals, whilst fears of compassion from others did not change over time. Health professionals, those with compassion training, older adults, and women showed greater flows of compassion and lower fears of compassion compared with the general population, those without compassion training, younger adults, and men. These findings highlight that, in a period of shared suffering, people from multiple countries and nationalities show a cumulative improvement in compassion and reduction in fears of compassion, suggesting that, when there is intense suffering, people become more compassionate to self and others and less afraid of, and resistant to, compassion